Mandate

Vinge advises EQT Infrastructure and Meine Radiologie / Blikk in connection with the acquisition of Aleris’ radiology business

Vinge advises EQT Infrastructure and its portfolio companies Meine Radiologie Holding GmbH and Blikk Holding GmbH in connection with the acquisition of Aleris’ radiology business.

The acquisition includes the full operation of the business area radiology, with 22 units in Sweden and 14 in Norway as well as teleradiology operations in the Baltics, which together carry out more than 1 million radiology exams annually across a broad range of diagnostic imaging modalities.

The acquisition is subject to approval from applicable competition authorities.

Vinge’s team consisted of partner Daniel Rosvall together with Carl Sander, Elsie Nassar, Clara Sohlberg and Ebba Nyberg (M&A), Sam Fakhraie Ardekani (Commercial Agreements), Benjamin Vafaeian (Banking and Financing), Christoffer Nordin (Regulatory and permits), Ulf Pyk (Real Estate), Tove Lövgren Frisk (Compliance), Gustav Lindgren (Employment), Lisa Hörnqvist and Karolina Fuhrman (IT and GDPR), Jolene Reimerson (Separation), Emma Gustavsson (IPR) and Ellinor Gyllenhammar (Project and VDR Assistant).

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025